Abstract:ObjectiveLynch syndrome is a malignant tumor syndrome with autosomal dominant inheritance. Preliminary screening of patients based on family history of tumor is currently the main method for Lynch syndrome screening. This study aimed to determine the proportion of colorectal cancer patients who met the clinical criteria of Lynch syndrome in China and were finally diagnosed with Lynch syndrome, as well as the opportunities and challenges that next-generation sequencing brought to the clinical diagnosis and treatment of Lynch syndrome. MethodsFrom February 2017 to October 2019, 85 unrelated patients were enrolled in 7 hospitals (The Second Affiliated Hospital, Zhejiang University School of Medicine; Peking Union Medical College Hospital; Jiangsu Province Hospital; Peking University First Hospital; Liaoning Cancer Hospital & Institute; West China Hospital; Wenzhou Central Hospital) with colorectal cancer who met the Chinese clinical criteria for Lynch syndrome, and detected the germline variants using a next-generation sequencing panel containing 61 genes that have been reported to be related to hereditary tumors. For the variants of uncertain clinical significance, the pathogenic significance of the variants is determined by Sanger sequencing and multiplex fluorescent PCR capillary electrophoresis to detect microsatellite status of tumor tissues. ResultsAmong the colorectal cancer patients who met the clinical criteria for Lynch syndrome in China, 28.2% were detected with pathogenic or likely pathogenic germline variants in Lynch syndrome-related genes, and 15.3% of patients carried variants of uncertain clinical significance of these genes. In the analysis of variants of uncertain significance, we suppose that the MLH1 read-through variant (c.2240_2255 delCTGATCTATACAAAGT) is a pathogenic variant of Lynch syndrome. Additionally, there is still insufficient evidence to show that MLH3 gene exon 2-11 duplication is closely related to the occurrence of hereditary colorectal cancer. ConclusionsThis study found that, also based on colorectal cancer patients who met the Chinese clinical criteria of Lynch syndrome, next-generation sequencing did not improve the diagnosis rate of Lynch syndrome compared with previous researches using Sanger sequencing. At the same time, it also brought a large number of variants of uncertain significance. Therefore, we need to be cautious about the results of genetic test. If necessary, in-depth pedigree research and comprehensive molecular testing should be carried out to clarify the clinical significance of these variants.

[Characteristics and Clinical Analysis of MLH1 C.463dupc Gene Mutation in a Lynch Syndrome Family].

Identification and verification of a pathogenic MLH1 mutation c.1145dupA in a Lynch syndrome family

MutL Homolog 1 Germline Mutation C.(453+1_454-1)_(545+1_546-1)del Identified in Lynch Syndrome: A Case Report and Review of Literature

A Chinese family affected by lynch syndrome caused by MLH1 mutation

Functional Characterization of a Missense Variant of MLH1 Identified in Lynch Syndrome Pedigree.

A new subtype of Lynch syndrome associated with MSH2 c.354T>A (p. Y118*) identified in a Chinese family: case report and literature review

A New Mutl Homolog 1 C.1896+5g>a Germline Mutation Detected in a Lynch Syndrome‐associated Lung and Gastric Double Primary Cancer Patient

RETRACTED: Functional Characterization of a Missense Variant of <i>MLH1</i> Identified in Lynch Syndrome Pedigree (Retracted Article)

A Novel MLH1 Initiation Codon Mutation (c.3g>t) in a Large Chinese Lynch Syndrome Family with Different Onset Age and Mrna Expression Level

Genetic spectrum of familial colorectal cancer based on Chinese clinical criteria of Lynch syndrome: study based on a multicenter population

A Frameshift Mutation in Exon 19 of MLH1 in a Chinese Lynch Syndrome Family: a Pedigree Study

A novel heterozygous large deletion of MSH6 gene in a Chinese family with Lynch syndrome

The Prevalence of Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

A Hereditable Mutation of MSH2 Gene Associated with Lynch Syndrome in a Five Generation Chinese Family.

Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

The Analysis for Identifying Large DNA Fragment Aberrations of MSH2 and MLH1 Genes from Familial Colorectal Cancer in China

Progress on the diagnosis, treatment, and family management of Lynch syndrome

Novel Germline Mutations in MLH1 and PMS2 in Familial Lynch Syndrome

Characteristics of Cancer in Subjects Carrying Lynch Syndrome-Associated Gene Variants in Taiwanese Population: A Hospital-Based Study in Taiwan

A Case of a New Lynch Syndrome Variant with a Deletion, C.1024_1026, in the MSH2 Gene in a Chinese Family

The MSH2 c.793-1G>A variant disrupts normal splicing and is associated with Lynch syndrome